LeMaitre Vascular: The Compounder Keeps Compounding
Source: SeekingAlpha
2026-02-27 15:01:26 ET
I last covered LeMaitre Vascular (NASDAQ:LMAT) at $81 in June 2025 , reiterating my Buy rating. Eight months later, shares are up about 35%, more than double that of the broader market. The stock jumped ~20% alone on the recent Q4 beat and raise, with 2026 guidance coming in 13% above Wall Street’s consensus. Pricing power, operating leverage, and international growth were all contributors....
Read the full article on Seeking Alpha
For further details see:
LeMaitre Vascular: The Compounder Keeps Compounding
LeMaitre Vascular Inc.
NASDAQ: LMAT
LMAT Trading
1.89% G/L:
$108.605 Last:
98,196 Volume:
$106.20 Open:
LMAT Latest News
February 11, 2026 09:47:47 am
LeMaitre Will Announce Fourth Quarter 2025 Earnings Results February 25, 2026
LMAT Stock Data
$1,988,654,234
20,530,825
0.06%
117
N/A
Medical Equipment & Supplies
Healthcare
US
Burlington
